82 related articles for article (PubMed ID: 7328576)
1. Interaction of 1-(5-phospho-beta-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-beta-D-arabinosyl)-5-fluorouracil.
Nakayama C; Wataya Y; Santi DV; Saneyoshi M; Ueda T
J Med Chem; 1981 Oct; 24(10):1161-5. PubMed ID: 7328576
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of selective inhibition of human cytomegalovirus replication by 1-beta-D-arabinofuranosyl-5-fluorouracil.
Suzuki S; Saneyoshi M; Nakayama C; Nishiyama Y; Yoshida S
Antimicrob Agents Chemother; 1985 Aug; 28(2):326-30. PubMed ID: 3010844
[TBL] [Abstract][Full Text] [Related]
3. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
Berger SH; Hakala MT
Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
[TBL] [Abstract][Full Text] [Related]
5. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.
Myers CE; Young RC; Chabner BA
J Clin Invest; 1975 Nov; 56(5):1231-8. PubMed ID: 1184747
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.
Spears CP; Gustavsson BG; Mitchell MS; Spicer D; Berne M; Bernstein L; Danenberg PV
Cancer Res; 1984 Sep; 44(9):4144-50. PubMed ID: 6744325
[TBL] [Abstract][Full Text] [Related]
7. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
[TBL] [Abstract][Full Text] [Related]
8. Interaction of N4-hydroxy-2'-deoxycytidylic acid with thymidylate synthetase.
Goldstein S; Pogolotti AL; Garvey EP; Santi DV
J Med Chem; 1984 Oct; 27(10):1259-62. PubMed ID: 6434741
[TBL] [Abstract][Full Text] [Related]
9. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
[TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates.
Fernandes DJ; Bertino JR
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5663-7. PubMed ID: 6160578
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthetase activity and fluorouracil sensitivity of human colonic cancer and normal mucosal tissue preparations.
Wolberg WH; Morin J
Cancer; 1981 Mar; 47(6):1313-7. PubMed ID: 7226054
[TBL] [Abstract][Full Text] [Related]
12. Vanoxonin, a new inhibitor of thymidylate synthetase. III. Inhibition of thymidylate synthetase by vanoxonin-vanadium complex.
Kanai F; Kaneko T; Morishima H; Isshiki K; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):39-50. PubMed ID: 3972727
[TBL] [Abstract][Full Text] [Related]
13. Perspective on the design and biochemical pharmacology of inhibitors of thymidylate synthetase.
Santi DV
J Med Chem; 1980 Feb; 23(2):103-11. PubMed ID: 6987403
[No Abstract] [Full Text] [Related]
14. Enhancement by thymidine of 5-fluorouracil's inhibition of thymidylate synthetase in human tumors.
Wolberg WH
Cancer Treat Rep; 1979; 63(11-12):1817-20. PubMed ID: 526916
[TBL] [Abstract][Full Text] [Related]
15. [Clinical pharmacology of anticancer agents (Part 4). Antimetabolites (1)].
Nakamura T; Uchida M; Ueda T
Gan To Kagaku Ryoho; 1992 Feb; 19(2):265-76. PubMed ID: 1736842
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of 2',5-difluoro-1-arabinosyluracil.
Coderre JA; Santi DV; Matsuda A; Watanabe KA; Fox JJ
J Med Chem; 1983 Aug; 26(8):1149-52. PubMed ID: 6876083
[TBL] [Abstract][Full Text] [Related]
17. Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft.
Radparvar S; Houghton PJ; Houghton JA
Biochem Pharmacol; 1989 Jan; 38(2):335-42. PubMed ID: 2914018
[TBL] [Abstract][Full Text] [Related]
18. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase.
Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF
Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950
[TBL] [Abstract][Full Text] [Related]
19. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
Helland S; Ueland PM
Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
[TBL] [Abstract][Full Text] [Related]
20. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]